4 Results for "

Bleximenib

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Bleximenib" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-148669
CAS No.: 2654081-35-1
Purity:  99.05%
Synonyms: JNJ-75276617; Menin-MLL inhibitor 24
Research Areas:  

Cancer

Bleximenib (JNJ-75276617) is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib can be used in the research of tumors such as leukemia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-148669A
CAS No.: 2866179-95-3
Purity:  ≥98.0%
Synonyms: JNJ-75276617 oxalate; Menin-MLL inhibitor 24 oxalate
Research Areas:  

Cancer

Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia .
loading...
    loading...
Cat. No.: HY-148669B
Purity:  98.37%
Synonyms: (S)-JNJ-75276617 oxalate; (S)-Menin-MLL inhibitor 24 oxalate
Research Areas:  

Cancer

(S)-Bleximenib (oxalate) is a S-Enantiomer of Bleximenib oxalate (HY-148669A). Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia .
loading...
    loading...
Cat. No.: HY-155797
CAS No.: 2654081-27-1
Synonyms: (S)-JNJ-75276617; (S)-Menin-MLL inhibitor 24
Target:  

Drug Isomer HOXA

Research Areas:  

Cancer

(S)-Bleximenib (Compound 28) ((S)-JNJ-75276617) is an isoform of Bleximenib (HY-148669). (S)-Bleximenib shows an IC50 greater than 1 μM in the MEIS1 mRNA expression assay. (S)-Bleximenib can be used in the research of acute myeloid leukemia .
loading...
    loading...